Leber- und Gallentumore | ICD10: C22-C24
Sie befinden sich hier:
Studien offen zur Rekrutierung
ACCTICA151 KB
eine multizentrische, randomisierte, kontrollierte Phase III Studie- adjuvante Chemotherapie mit Gemcitabin und Cisplatin bei Patienten mit Gallengangskrebs nach kompletter chirurgischer Entfernung
CONTRAIL I84 KB
A 12-month, Open-label, Multicenter, Randomized, Safety, Efficacy, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of an Anti-CD40 Monoclonal Antibody, CFZ533 vs. Standard of Care Control, in Adult de Novo Liver Transplant Recipients With a 12-month Additional Follow-up (CONTRAIL I)
HepaStar95 KB
Investigate the use of DSM-TACE in a large-scale, collaborative, non-interventional study
MASTERKEY-318 (20140318)54 KB
Trial to Evaluate the Safety of Talimogene Laherparepvec Injected into Liver Tumors Alone and in Combination With Systemic Pembrolizumab
MK-3475-937 (KEYNOTE-937)94 KB
A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma and Complete Radiological Response After Surgical Resection or Local Ablation (KEYNOTE-937)